| scholarly article | Q13442814 |
| P2093 | author name string | Goo Jang | |
| Soo-Young Yum | |||
| Kyung-Sun Kang | |||
| Young-Jin Choi | |||
| Pyung-Hwan Kim | |||
| Je-Yoel Cho | |||
| Hyun-Kyung Chang | |||
| Hyun-Min Cho | |||
| YeonSung Son | |||
| DaBin Lee | |||
| InSung Kang | |||
| P2860 | cites work | Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D-glucose in human endothelial cells | Q43618959 |
| In vivo transfer of human hepatocyte growth factor gene accelerates re-endothelialization and inhibits neointimal formation after balloon injury in rat model | Q45032198 | ||
| A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function | Q47724235 | ||
| Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis | Q50674319 | ||
| HGF-Met Pathway in Regeneration and Drug Discovery. | Q50977859 | ||
| Injectable multifunctional microgel encapsulating outgrowth endothelial cells and growth factors for enhanced neovascularization. | Q51733340 | ||
| Umbilical-cord-blood-derived mesenchymal stem cells seeded onto fibronectin-immobilized polycaprolactone nanofiber improve cardiac function. | Q53592436 | ||
| HGF/Met Axis in Heart Function and Cardioprotection. | Q54256769 | ||
| Hepatocyte growth factor: Mesenchymal signal for epithelial homeostasis | Q57691472 | ||
| Potential role of an endothelium-specific growth factor, hepatocyte growth factor, on endothelial damage in diabetes | Q71909318 | ||
| Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor | Q71953088 | ||
| Promotion of cardiac regeneration by cardiac stem cells | Q81287313 | ||
| Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction | Q81884186 | ||
| Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product | Q24310794 | ||
| Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor | Q24564783 | ||
| Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes | Q24644691 | ||
| Adult Stem Cell Plasticity: Fact or Artifact? | Q28211482 | ||
| A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family | Q28285975 | ||
| Adult versus embryonic stem cells: treatments | Q28305541 | ||
| Paracrine mechanisms in adult stem cell signaling and therapy | Q29620571 | ||
| Stable enhanced green fluorescent protein expression after differentiation and transplantation of reporter human induced pluripotent stem cells generated by AAVS1 transcription activator-like effector nucleases. | Q30422111 | ||
| Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice | Q35229384 | ||
| Vascular endothelial growth factor as a target for anticancer therapy | Q35792723 | ||
| HGF/SF-Met signaling in tumor progression | Q36027374 | ||
| Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. | Q36874456 | ||
| Integrated glycoproteomics demonstrates fucosylated serum paraoxonase 1 alterations in small cell lung cancer. | Q37428849 | ||
| Defining adipose tissue-derived stem cells in tissue and in culture | Q37727102 | ||
| The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy. | Q37771492 | ||
| Cellular and molecular mechanisms of HGF/Met in the cardiovascular system. | Q38631649 | ||
| Prostate cancer stem-like cells/cancer-initiating cells have an autocrine system of hepatocyte growth factor | Q39210179 | ||
| Inhibition of proliferation and induction of apoptosis by doxycycline in cultured human osteosarcoma cells | Q41077817 | ||
| In vivo genome editing using a high-efficiency TALEN system | Q41438039 | ||
| P433 | issue | 9 | |
| P921 | main subject | angiogenesis | Q539568 |
| P304 | page(s) | 1644-1654 | |
| P577 | publication date | 2016-07-19 | |
| P1433 | published in | Molecular Therapy | Q15762400 |
| P1476 | title | Inducible HGF-secreting Human Umbilical Cord Blood-derived MSCs Produced via TALEN-mediated Genome Editing Promoted Angiogenesis | |
| P478 | volume | 24 |
| Q58769716 | Coronary stents with inducible VEGF/HGF-secreting UCB-MSCs reduced restenosis and increased re-endothelialization in a swine model |
| Q52718163 | Donor-dependent variation of human umbilical cord blood mesenchymal stem cells in response to hypoxic preconditioning and amelioration of limb ischemia. |
| Q42367794 | Hedgehog-Interacting Protein (HIP) Regulates Apoptosis Evasion and Angiogenic Function of Late Endothelial Progenitor Cells |
| Q92521567 | Mesenchymal stem cells ameliorate β cell dysfunction of human type 2 diabetic islets by reversing β cell dedifferentiation |
| Q92423873 | Optimization of lentiviral transduction parameters and its application for CRISPR-based secretome modification of human endometrial mesenchymal stem cells |
| Q47595752 | Strategies to retain properties of bone marrow-derived mesenchymal stem cells ex vivo |
| Q28066984 | Therapeutic Potential of Human Mesenchymal Stem Cells for Treating Ischemic Limb Diseases |
Search more.